Clinical Trials Directory

Trials / Completed

CompletedNCT02674607

the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
4 Years – 18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate the possible immunologic effects of spirulina in children with beta thalassemia.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSpirulina

Timeline

Start date
2015-10-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2016-02-04
Last updated
2017-10-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02674607. Inclusion in this directory is not an endorsement.